Financials Shilpa Medicare Limited

Equities

SHILPAMED

INE790G01031

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:51 2024-07-22 am EDT 5-day change 1st Jan Change
643.8 INR +2.13% Intraday chart for Shilpa Medicare Limited -2.40% +94.84%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 37,259 27,735 19,933 27,214 34,473 19,908
Enterprise Value (EV) 1 37,238 29,335 23,410 34,445 41,053 27,699
P/E ratio 35.6 x 24.7 x 12.8 x 18.4 x 54.7 x -61.3 x
Yield 0.15% 0.29% 0.45% 0.33% 0.28% -
Capitalization / Revenue 4.72 x 3.78 x 2.19 x 3.02 x 3.01 x 1.89 x
EV / Revenue 4.72 x 4 x 2.58 x 3.82 x 3.58 x 2.63 x
EV / EBITDA 24.7 x 19 x 10.9 x 20.2 x 20.7 x 32 x
EV / FCF -38.1 x -13.1 x -10.5 x -8.55 x -17.5 x -25.1 x
FCF Yield -2.63% -7.62% -9.56% -11.7% -5.72% -3.98%
Price to Book 3.49 x 2.32 x 1.5 x 1.84 x 1.89 x 1.12 x
Nbr of stocks (in thousands) 80,127 81,527 81,527 81,527 86,802 86,802
Reference price 2 465.0 340.2 244.5 333.8 397.2 229.4
Announcement Date 8/28/18 8/29/19 8/15/20 9/4/21 9/5/22 9/5/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 7,894 7,337 9,082 9,016 11,469 10,517
EBITDA 1 1,509 1,545 2,144 1,709 1,981 865.4
EBIT 1 1,148 1,141 1,723 1,188 1,204 -54
Operating Margin 14.54% 15.55% 18.97% 13.17% 10.5% -0.51%
Earnings before Tax (EBT) 1 1,368 1,357 1,881 1,951 1,023 -382.8
Net income 1 1,052 1,123 1,562 1,478 606.6 -324.8
Net margin 13.33% 15.3% 17.19% 16.39% 5.29% -3.09%
EPS 2 13.07 13.77 19.15 18.13 7.260 -3.741
Free Cash Flow 1 -978.2 -2,234 -2,238 -4,028 -2,348 -1,104
FCF margin -12.39% -30.46% -24.64% -44.67% -20.47% -10.5%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 0.7000 1.000 1.100 1.100 1.100 -
Announcement Date 8/28/18 8/29/19 8/15/20 9/4/21 9/5/22 9/5/23
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 1,912 2,080 2,374 2,953 2,723 3,406 2,612 2,629 2,625
EBITDA 1 209.7 262.5 318.8 531.6 450.9 737.3 205.7 122 312.9
EBIT - - - - - - - - -
Operating Margin - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - -
Net income - - - - - - - - -
Net margin - - - - - - - - -
EPS - - - - - - - - -
Dividend per Share - - - - - - - - -
Announcement Date 2/13/21 5/31/21 8/14/21 10/29/21 2/8/22 5/23/22 8/11/22 11/11/22 2/14/23
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 1,599 3,477 7,231 6,579 7,791
Net Cash position 1 21.2 - - - - -
Leverage (Debt/EBITDA) - 1.035 x 1.622 x 4.23 x 3.322 x 9.002 x
Free Cash Flow 1 -978 -2,234 -2,238 -4,028 -2,348 -1,104
ROE (net income / shareholders' equity) 9.97% 9.65% 12.3% 10.5% 3.7% -1.72%
ROA (Net income/ Total Assets) 4.78% 4.59% 5.99% 3.21% 2.73% -0.12%
Assets 1 22,039 24,478 26,072 46,059 22,200 278,051
Book Value Per Share 2 133.0 147.0 163.0 181.0 210.0 205.0
Cash Flow per Share 2 9.030 4.200 5.440 15.10 3.900 2.460
Capex 1 1,380 3,000 3,493 3,542 3,318 2,725
Capex / Sales 17.48% 40.89% 38.46% 39.29% 28.93% 25.91%
Announcement Date 8/28/18 8/29/19 8/15/20 9/4/21 9/5/22 9/5/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SHILPAMED Stock
  4. Financials Shilpa Medicare Limited